WO2005034778A1 - Lancing device end cap with flexing contact elements - Google Patents

Lancing device end cap with flexing contact elements Download PDF

Info

Publication number
WO2005034778A1
WO2005034778A1 PCT/US2004/024280 US2004024280W WO2005034778A1 WO 2005034778 A1 WO2005034778 A1 WO 2005034778A1 US 2004024280 W US2004024280 W US 2004024280W WO 2005034778 A1 WO2005034778 A1 WO 2005034778A1
Authority
WO
WIPO (PCT)
Prior art keywords
endcap
fingers
skin
lancing device
sampling site
Prior art date
Application number
PCT/US2004/024280
Other languages
French (fr)
Inventor
Stephen Flynn
Richard W. Levaughn
Christopher J. Ruf
Gwenn E. Kennedy
Michael V. Lipoma
Juan D. Salleras
Jac Holzaepfel
Sylvia Ramos
Original Assignee
Facet Technologies, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Facet Technologies, Llc filed Critical Facet Technologies, Llc
Publication of WO2005034778A1 publication Critical patent/WO2005034778A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150015Source of blood
    • A61B5/150022Source of blood for capillary blood or interstitial fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150053Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
    • A61B5/150061Means for enhancing collection
    • A61B5/150068Means for enhancing collection by tissue compression, e.g. with specially designed surface of device contacting the skin area to be pierced
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150748Having means for aiding positioning of the piercing device at a location where the body is to be pierced
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15103Piercing procedure
    • A61B5/15105Purely manual piercing, i.e. the user pierces the skin without the assistance of any driving means or driving devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15142Devices intended for single use, i.e. disposable

Definitions

  • the present invention relates generally to medical devices and procedures, and more particularly to lancing devices for sampling blood or other bodily fluids.
  • the invention more particularly relates to an end cap for use in conjunction with a lancing device that allows for the collection of an increased volume of blood or bodily fluid to be sampled.
  • a lancet having a sharp lancing tip typically is mounted, permanently or releasably, to the drive mechanism of a lancing device.
  • the drive mechanism includes one or more springs, cams, motors, or other mechanism(s) for moving the lancing tip from a retracted position shielded within a housing of the lancing device to an extended position outside of the housing for lancing the subject's skin.
  • the lancing device may also include a cocking mechanism for arming the drive mechanism, and/or a triggering mechanism for firing the device.
  • the housing of the lancing device typically includes an endcap with an opening through which the lancing tip extends in its extended position.
  • the endcap may be releasably or permanently attached to the remainder of the housing, or can comprise an integral part of the housing.
  • the repeated application and release of pressure from such pumping can result in contact between the sample and the lancing device, smearing and/or contaminating the sample and necessitating another lancing operation, and/or can lead to bruising of the tissue surrounding the sampling site.
  • the provision of a translationally mounted stimulator member results in increased complexity and cost of the lancing device.
  • the present invention is an endcap for a lancing device that enables collection of an increased volume of blood or other body fluid to be sampled from a sampling site of a human or animal subject.
  • the device of the present invention is suitable for use at fingertip sampling sites, but is also well suited for use at alternate sampling sites such as the forearm and/or eariobe.
  • the invention is a sampling method for increasing collected sample size of blood or other body fluid from a sampling site.
  • the present invention is an endcap for a lancing device.
  • the endcap preferably has a first end for connection to the lancing device, a second end for contacting the skin around a sampling site, and at least one flexible finger extending toward 1J ⁇ e_s ⁇ j ⁇ C ⁇ i Le ⁇ JQr--contactic ⁇ g--and manipulafmg-the- ⁇ kin-atthe-saro lin -site.
  • the invention is a lancing device for collecting a sample of body fluid from a sampling site on the skin of a subject.
  • the lancing device preferably includes a lancet and a housing comprising an endcap, the lancet being movable between a first position within the housing and a second position wherein at least a sharp tip portion of the lancet extends through the endcap.
  • the endcap preferably includes at least one flexible contact element for contacting and manipulating the skin at the sampling site.
  • the invention is a lancing device having an opening for passing at least a sharp tip portion of a lancet therethrough, and a contact face surrounding the opening for contact against the skin around a sampling site.
  • the lancing device preferably also includes at least one flexible member having a free end extending beyond the contact face in its unflexed state.
  • the invention is a method of lancing skin to collect a fluid sample, the method preferably including the steps of pressing a lancing device into contact with the skin adjacent a sampling site, lancing the skin at the sampling site, and actuating at least one flexible finger to flex and manipulate tissue adjacent the sampling site.
  • FIGURES 1a-1c show perspective views of endcaps for a lancing device, according to example embodiments of the present invention.
  • FIGURES 2a and 2b show .perspective and side views of an endcap for a lancing device according to another example embodiment of the present invention.
  • FIGURES 3a and 3b show perspective and side views of an endcap for a lancing device according to a further example embodiment of the present invention.
  • FIGURES 4a and 4b show perspective and side views of an endcap for a lancing device according to another example embodiment of the present invention.
  • FIGURES 5a and 5b show perspective and side views of an endcap for a lancing device according to still another example embodiment of the present invention. Detailed Description of Example Embodiments
  • Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent "about,” it will be understood that the particular value forms another embodiment.
  • Figures 1a, 1 b and 1c show example embodiments of an endcap 10 for a lancing device according to the present invention (corresponding features of the embodiments of Figs. 1 b and 1 c are indicated with single prime and double-prime reference numbers, respectively).
  • the endcap 10 preferably comprises a first end 12 for releasable or permanent attachment to the remainder of a housing of a lancing device. Alternatively, the endcap forms an integral part of the housing of the lancing device.
  • the endcap 10 can be adapted for use with any of a variety of standard, commercially-available or later-developed lancing devices, by appropriate configuration of coupling or attachment features of the first end 12.
  • the second end 14 of the endcap 10 preferably defines the opening 16 through which the sharp lancet tip projects in its extended position to penetrate the skin at the intended sampling site.
  • the opening 16 is a generally square opening formed at or near the center of the second end 14 of the endcap 10.
  • the opening is a slot or an opening of circular, triangular, rectangular, polygonal or other shape.
  • the second end 14 of the endcap 10 preferably comprises a contact ring or face 20, for placement against the skin around the sampling site.
  • One or more flexible fingers 22 extend from the endcap adjacent to the opening 16, projecting obliquely forward and curving inward from the periphery of the opening.
  • the flexible fingers 22 project from the four sides of the opening 16 in the embodiments of Figs. 1 a and 1 b, and two flexible fingers project from opposed sides of the opening in the embodiment of Fig. 1 c.
  • the flexible fingers 22 optionally taper from wider and/or thicker at their root ends where they are connected to the endcap to narrower and/or thinner at their free ends, to provide progressively increasing flexure toward the free ends.
  • the fingers 22 comprise one or more thin regions, notches or other points of weakness, which act as a hinge point during flexure.
  • the free edges or tips of the fingers 22 are optionally turned forward, as shown in Figs.
  • the flexible fingers are preferably formed of an engineering or medical-grade polymer, plastic or other flexible, resilient material.
  • the fingers 22 are preferably formed as integral portions of a unitary endcap, as by injection molding or the like; or alternatively are separately formed and attached to the body of the endcap by adhesive, welding, solvent or thermal bonding, snap-fittings, couplings, connectors, or other attachment means.
  • the second end 14 of the endcap 10 is pressed against the subject's skin around the sampling site prior to, during, and/or after lancing, causing the fingers 22 to flex inwardly until the contact ring 20 is pressed firmly against the skin, with the fingers engaging and pinching the skin at the sampling site to direct subcutaneous blood toward the sampling site. Maintaining or applying pressure of the endcap against the skin around the sampling site during and after lancing further assists in expressing blood out of the wound for sample collection, and causes the skin to bulge slightly to prevent premature closure of the sampling site wound.
  • Figures 2a and 2B show an endcap 30 for a lancing device according to another embodiment of the present invention.
  • Lengthwise slits through at least a forward portion of the endcap 30 proximal the second end 32 divide the endcap into a plurality of fingers, at least one of which is a compressible finger.
  • These fingers of the endcap 30 are preferably tapered inwardly toward the second end 32 of the endcap, and are formed of a flexible resilient material.
  • four slits divide the endcap into four fingers, two of which are compressible fingers 34, and two of which are non-compressible fingers 36.
  • the compressible fingers 34 preferably comprise an angled or accordion- folded hinged section formed of flexible resilient material, which compresses when the endcap 30 is pressed against the subject's skin.
  • the non-compressible fingers 36 preferably comprise generally flat forward faces for contact with the subject's skin, and defining an opening therebetween for allowing passage of the sharp lancet tip.
  • the compressible fingers 34 are preferably longer than the non-compressible fingers 36, and extend beyond the non-compressible fingers in the direction of the second end 32 of the endcap 30.
  • the compressible fingers 34 compress until the forward faces of T-he-inward-tape o the endcap 30 coupled with the compression of the compressible fingers 34 preferably causes the fingers 34, 36 to flex inwardly upon pressing the endcap against the skin, pooling blood at the sampling site prior to iancing, and helping to express blood from the sampling site and prevent wound closure after lancing.
  • FIGs 3a and 3b show an endcap 50 for a lancing device according to another embodiment of the present invention.
  • the second end 52 of this endcap embodiment comprises a plurality of flexible fingers 54, which taper outwardly toward the second end of the endcap.
  • the free ends of the fingers 54 optionally comprise contact faces that are obliquely angled, tapering outwardly and away from the first end of the endcap.
  • An opening is preferably defined between the contact faces for passing the sharp lancet tip.
  • the fingers 54 preferably flex outwardly, tensioning the skin at the sampling site.
  • the sharp lancet tip is a blade having a transverse penetration edge (as opposed to a needle having a pointed penetration tip)
  • one or more of the fingers 54 is configured to be more or less flexible than one or more other fingers, to impart tension to the skin in a specified direction.
  • a first opposed pair of fingers has a greater thickness (and thereby a lower degree of flexure upon application of pressure) than a second opposed pair of fingers oriented perpendicular to the first pair.
  • application of pressure causes a greater degree of flexure of the second pair of fingers, tensioning the skin to a greater extent in the direction extending between the fingers of the second pair.
  • Figures 4a and 4b show an endcap 70 for a lancing device according to another embodiment of the present invention.
  • the flexing fingers 74 are preferably tapered or biased obliquely outwardly toward their free ends, and preferably include a barb or projection 78 adjacent their free ends.
  • a collett ring 80 is slideably mounted around the flexing fingers 74, between the barbs 78 and a retaining flange 82 proximal the first end of the endcap 70, as indicated by directional arrow 84. Sliding the collett ring 80 toward the second end 72 of the endcap 70 causes the flexing fingers 74 to flex inwardly, and sliding the collett ring toward the first end of the endcap allows the flexing fingers to return to their outwardly tapered positions.
  • the collett ring optionally comprises a ribbed or knurled outer surface for improved manual gripping.
  • the non-flexing fingers 76 optionally comprise flat or tapered contact faces at their free ends for contacting the subject's skin around the sampling site, and defining an opening therebetween for allowing passage of the lancet tip.
  • the flexing fingers 74 are preferably longer than the non-flexing fingers 76, and extend beyond the non-flexing fingers in the direction of the second end 72 of the endcap 70. The second end 72 of the endcap is pressed against the skin at the sampling site, the skin is lanced, and the collett ring 80 is slid toward the second end of the endcap (prior to, during or after the lancing step) to move the flexing fingers 74 inwardly to direct subcutaneous blood toward the sampling site wound, where it is expressed for sample collection.
  • Figures 5a and 5b show an endcap 90 for a lancing device according to still another embodiment of the present invention.
  • the second end 92 of this endcap embodiment comprises a contact face 94 defining a generally central opening 96 for passage of the lancet tip therethrough.
  • At least one (four are shown) flexible finger(s) 98 are attached to the endcap proximal the first end of the endcap, and have free ends projecting beyond the contact face 94 at the second end 92 of the endcap.
  • the fingers 98 are outwardly bowed, with their free ends tapered inwardly.
  • Pressing the second end 92 of the endcap 90 against the skin around the sampling site causes HeA ⁇ ngers-to-bow ⁇ further -and-thereby-bends-the ' i -free- ends-fufthef-inwareHy; compressing the skin at the sampling site to direct blood toward the wound and help prevent premature closure of the wound.
  • the fingers 98 are bowed inwardly with their free ends tapered outwardly, such that pressing the endcap against the skin around the sampling site bends the free ends further outwardly and tensions the skin to prevent wound closure.
  • one or more fingers are bowed outwardly and tapered inwardly at their free ends, and one or more fingers are bowed inwardly and tapered outwardly at their free ends, such that pressure against the skin compresses the skin in one direction and tensions the skin in another direction.
  • the second end of the endcap of the lancing device is pressed into contact with the subject's skin at the sampling site, the skin is lanced, and the sample is collected.
  • the fingers of the endcap are actuated (as by compression, manipulation of a collett ring, or otherwise) to flex inwardly and/or outwardly, and thereby compress, tension, slide in contact with, and/or otherwise manipulate the tissue at and/or around the sampling site, prior to lancing of the skin.
  • the fingers are acutated to flex inwardly and/or outwardly to manipulate the tissue at and/or around the sampling site during and/or after lancing of the skin.
  • subcutaneous blood can be directed by action of the fingers to pool in the area of the sampling site prior to or during lancing, and/orthe blood can be expressed out of the wound by action of the fingers during or after lancing, and/or the wound can be maintained open by the fingers to prevent premature closure.

Abstract

An endcap (10) for a lancing device having at least one flexible finger (22) for manipulating tissue at the sampling site. Pressing the lancing device against the skin at the lancing site flexes the finger (22) inwardly or outwardly to pinch or tension the skin, directing subcutaneous blood-flow toward the sampling site and preventing premature wound closure.

Description

LANCING DEVICE END CAP WITH FLEXING CONTACT ELEMENTS
Cross-Reference to Related Application
[0001] This application claims the benefit of U.S. Provisional Patent Application
Serial No. 60/503,839, filed September 18, 2003, the entirety of which is hereby incorporated herein by reference for all purposes.
Technical Field
[0002] The present invention relates generally to medical devices and procedures, and more particularly to lancing devices for sampling blood or other bodily fluids. The invention more particularly relates to an end cap for use in conjunction with a lancing device that allows for the collection of an increased volume of blood or bodily fluid to be sampled.
Background of the Invention
[0003] Many medical procedures require puncturing of the skin, and sometimes underlying tissues, of a human or animal subject. For example, a sharp lancet tip is commonly used to puncture the subject's skin for sampling of blood or other body fluid, as for example in blood glucose monitoring by diabetics. Generally, lancet blades or needles
Figure imgf000003_0001
pain to the patient. A lancet having a sharp lancing tip typically is mounted, permanently or releasably, to the drive mechanism of a lancing device. The drive mechanism includes one or more springs, cams, motors, or other mechanism(s) for moving the lancing tip from a retracted position shielded within a housing of the lancing device to an extended position outside of the housing for lancing the subject's skin. The lancing device may also include a cocking mechanism for arming the drive mechanism, and/or a triggering mechanism for firing the device. The housing of the lancing device typically includes an endcap with an opening through which the lancing tip extends in its extended position. The endcap may be releasably or permanently attached to the remainder of the housing, or can comprise an integral part of the housing. [0004] One common problem that has been found to exist with many known lancets and lancing devices is the closure of the puncture site before an adequate volume of blood has been collected. Premature closure of the puncture requires additional blood to be drawn from the patient, often in a separate and sometimes less desirable location, resulting in an increase in pain and stress to the subject. Costs also increase, as multiple lancets are required to acquire an adequate sample. This is particularly the case when alternate sampling sites other than the fingertips, such as for example the forearm or earlobe, are lanced. Lancing at such alternate sampling sites may be desirable because repeated lancing of the fingertips can result in callous formation, leading to less consistent sampling and decreased sensitivity of the fingertips. In addition, the fingertips have a greater density of nerve endings than alternate sampling sites, resulting in greater pain sensation from fingertip lancing than lancing at alternate sites. To increase patient compliance with a prescribed sampling regimen, it is desirable to minimize pain resulting from the lancing operation. However, because alternate sites typically contain a lower density of capillaries or a deeper capillary bed than the fingertips, alternate sampling sites often yield insufficient sample sizes or are prone to premature closure.
[0005] Attempts have been made to provide lancing devices that inhibit premature closure of the puncture site and yield increased sample size. Such attempts have included -the- use of a-stιmtιlatør-member-sHdab.y-mθtfFrted-te- the-h©using-fer -eyelieally-pumping around the puncture site to "milk" the wound. Although utilizing the aforementioned pumping sequence may allow a larger sample to be collected before closure of the puncture site, occasionally a sample is stϊϋ insufficient, and another lancing operation to collect blood or analytic fluid is required. Additionally, the repeated application and release of pressure from such pumping can result in contact between the sample and the lancing device, smearing and/or contaminating the sample and necessitating another lancing operation, and/or can lead to bruising of the tissue surrounding the sampling site. Also, the provision of a translationally mounted stimulator member results in increased complexity and cost of the lancing device. [0006] Thus it can be seen that needs exist for improved lancing devices and methods to facilitate increased sample volume of blood or other analytic fluid, and to prevent premature closure of the wound at the sampling site. Needs further exist for such mechanisms and methods that are readily adaptable to current lancing devices and procedures, and which can be utilized for lancing at fingertip as well as alternate sample collection sites.
Summary of the Invention
[0007] In example forms, the present invention is an endcap for a lancing device that enables collection of an increased volume of blood or other body fluid to be sampled from a sampling site of a human or animal subject. The device of the present invention is suitable for use at fingertip sampling sites, but is also well suited for use at alternate sampling sites such as the forearm and/or eariobe. In further embodiments, the invention is a sampling method for increasing collected sample size of blood or other body fluid from a sampling site.
[0008] In one aspect, the present invention is an endcap for a lancing device. The endcap preferably has a first end for connection to the lancing device, a second end for contacting the skin around a sampling site, and at least one flexible finger extending toward 1Jπe_sβjϊCϋi LeήάJQr--contacticιg--and manipulafmg-the-^kin-atthe-saro lin -site.
[0009] In another aspect, the invention is a lancing device for collecting a sample of body fluid from a sampling site on the skin of a subject. The lancing device preferably includes a lancet and a housing comprising an endcap, the lancet being movable between a first position within the housing and a second position wherein at least a sharp tip portion of the lancet extends through the endcap. The endcap preferably includes at least one flexible contact element for contacting and manipulating the skin at the sampling site.
[00010] In still another aspect, the invention is a lancing device having an opening for passing at least a sharp tip portion of a lancet therethrough, and a contact face surrounding the opening for contact against the skin around a sampling site. The lancing device preferably also includes at least one flexible member having a free end extending beyond the contact face in its unflexed state.
[00011 ] In another aspect, the invention is a method of lancing skin to collect a fluid sample, the method preferably including the steps of pressing a lancing device into contact with the skin adjacent a sampling site, lancing the skin at the sampling site, and actuating at least one flexible finger to flex and manipulate tissue adjacent the sampling site.
[00012] These and other aspects, features and advantages of the invention will be understood with reference to the drawing figures and detailed description herein, and will be realized by means of the various elements and combinations particularly pointed out in the appended claims. It is to be understood that both the foregoing general description and the following brief description of the drawings and detailed description of the invention are exemplary and explanatory of preferred embodiments of the invention, and are not restrictive of the invention, as claimed.
Brief Description of the Drawings
[00013] FIGURES 1a-1c show perspective views of endcaps for a lancing device, according to example embodiments of the present invention.
[00014] FIGURES 2a and 2b show .perspective and side views of an endcap for a lancing device according to another example embodiment of the present invention.
[00015] FIGURES 3a and 3b show perspective and side views of an endcap for a lancing device according to a further example embodiment of the present invention.
[00016] FIGURES 4a and 4b show perspective and side views of an endcap for a lancing device according to another example embodiment of the present invention.
[00017] FIGURES 5a and 5b show perspective and side views of an endcap for a lancing device according to still another example embodiment of the present invention. Detailed Description of Example Embodiments
[00018] The present invention may be understood more readily by reference to the following detailed description of the invention taken in connection with the accompanying drawing figures, which form a part of this disclosure. It is to be understood that this invention is not limited to the specific devices, methods, conditions or parameters described and/or shown herein, and that the terminology used herein is for the purpose of describing particular embodiments by way of example only and is not intended to be limiting of the claimed invention. Also, as used in the specification including the appended claims, the singular forms "a," "an," and "the" include the plural, and reference to a particular numerical value includes at least that particular value, unless the context clearly dictates otherwise. Ranges may be expressed herein as from "about" or "approximately" one particular value and/or to "about" or "approximately" another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent "about," it will be understood that the particular value forms another embodiment.
[00019] With reference now to the drawing figures, Figures 1a, 1 b and 1c show example embodiments of an endcap 10 for a lancing device according to the present invention (corresponding features of the embodiments of Figs. 1 b and 1 c are indicated with single prime and double-prime reference numbers, respectively). The endcap 10 preferably comprises a first end 12 for releasable or permanent attachment to the remainder of a housing of a lancing device. Alternatively, the endcap forms an integral part of the housing of the lancing device. The endcap 10 can be adapted for use with any of a variety of standard, commercially-available or later-developed lancing devices, by appropriate configuration of coupling or attachment features of the first end 12. The second end 14 of the endcap 10 preferably defines the opening 16 through which the sharp lancet tip projects in its extended position to penetrate the skin at the intended sampling site. [00020] In the depicted embodiment, the opening 16 is a generally square opening formed at or near the center of the second end 14 of the endcap 10. In alternate embodiments, the opening is a slot or an opening of circular, triangular, rectangular, polygonal or other shape. The second end 14 of the endcap 10 preferably comprises a contact ring or face 20, for placement against the skin around the sampling site. One or more flexible fingers 22 extend from the endcap adjacent to the opening 16, projecting obliquely forward and curving inward from the periphery of the opening. Four flexible fingers 22 (two opposed pairs) project from the four sides of the opening 16 in the embodiments of Figs. 1 a and 1 b, and two flexible fingers project from opposed sides of the opening in the embodiment of Fig. 1 c. The flexible fingers 22 optionally taper from wider and/or thicker at their root ends where they are connected to the endcap to narrower and/or thinner at their free ends, to provide progressively increasing flexure toward the free ends. Alternatively or additionally, the fingers 22 comprise one or more thin regions, notches or other points of weakness, which act as a hinge point during flexure. The free edges or tips of the fingers 22 are optionally turned forward, as shown in Figs. 1 b and 1c, and have an angled chisel edge to better engage the skin around the sampling site. The flexible fingers are preferably formed of an engineering or medical-grade polymer, plastic or other flexible, resilient material. The fingers 22 are preferably formed as integral portions of a unitary endcap, as by injection molding or the like; or alternatively are separately formed and attached to the body of the endcap by adhesive, welding, solvent or thermal bonding, snap-fittings, couplings, connectors, or other attachment means.
[00021] The second end 14 of the endcap 10 is pressed against the subject's skin around the sampling site prior to, during, and/or after lancing, causing the fingers 22 to flex inwardly until the contact ring 20 is pressed firmly against the skin, with the fingers engaging and pinching the skin at the sampling site to direct subcutaneous blood toward the sampling site. Maintaining or applying pressure of the endcap against the skin around the sampling site during and after lancing further assists in expressing blood out of the wound for sample collection, and causes the skin to bulge slightly to prevent premature closure of the sampling site wound.
[00022] Figures 2a and 2B show an endcap 30 for a lancing device according to another embodiment of the present invention. Lengthwise slits through at least a forward portion of the endcap 30 proximal the second end 32 divide the endcap into a plurality of fingers, at least one of which is a compressible finger. These fingers of the endcap 30 are preferably tapered inwardly toward the second end 32 of the endcap, and are formed of a flexible resilient material. In the depicted embodiment, four slits divide the endcap into four fingers, two of which are compressible fingers 34, and two of which are non-compressible fingers 36. The compressible fingers 34 preferably comprise an angled or accordion- folded hinged section formed of flexible resilient material, which compresses when the endcap 30 is pressed against the subject's skin. The non-compressible fingers 36 preferably comprise generally flat forward faces for contact with the subject's skin, and defining an opening therebetween for allowing passage of the sharp lancet tip. The compressible fingers 34 are preferably longer than the non-compressible fingers 36, and extend beyond the non-compressible fingers in the direction of the second end 32 of the endcap 30. When the second end 32 of the endcap 30 is pressed against the subject's skin at the sampling site, the compressible fingers 34 compress until the forward faces of
Figure imgf000009_0001
T-he-inward-tape o the endcap 30 coupled with the compression of the compressible fingers 34 preferably causes the fingers 34, 36 to flex inwardly upon pressing the endcap against the skin, pooling blood at the sampling site prior to iancing, and helping to express blood from the sampling site and prevent wound closure after lancing.
[00023] Figures 3a and 3b show an endcap 50 for a lancing device according to another embodiment of the present invention. The second end 52 of this endcap embodiment comprises a plurality of flexible fingers 54, which taper outwardly toward the second end of the endcap. The free ends of the fingers 54 optionally comprise contact faces that are obliquely angled, tapering outwardly and away from the first end of the endcap. An opening is preferably defined between the contact faces for passing the sharp lancet tip. As the second end 52 of the endcap 50 is pressed against the subject's skin around the sampling site, the fingers 54 preferably flex outwardly, tensioning the skin at the sampling site. Maintaining pressure on the lancing device after lancing thus tends to pull the sampling site wound open, preventing premature closure. If the sharp lancet tip is a blade having a transverse penetration edge (as opposed to a needle having a pointed penetration tip), it is preferable to align the blade in the lancing device such that the fingers apply tension to the skin perpendicular to the cutting edge of the blade, thereby further enhancing the tendency to open the wound. Optionally, one or more of the fingers 54 is configured to be more or less flexible than one or more other fingers, to impart tension to the skin in a specified direction. For example, in the depicted embodiment, a first opposed pair of fingers has a greater thickness (and thereby a lower degree of flexure upon application of pressure) than a second opposed pair of fingers oriented perpendicular to the first pair. In this manner, application of pressure causes a greater degree of flexure of the second pair of fingers, tensioning the skin to a greater extent in the direction extending between the fingers of the second pair.
[00024] Figures 4a and 4b show an endcap 70 for a lancing device according to another embodiment of the present invention. The second end 72 of this endcap embodiments mpr.ses-a-plujsfity-of inger-s^ depicted embodiment, an alternating array of four flexing fingers 74 and four non-flexing fingers 76 is provided. In alternate embodiments, all of the fingers are flexing fingers. The flexing fingers 74 are preferably tapered or biased obliquely outwardly toward their free ends, and preferably include a barb or projection 78 adjacent their free ends. A collett ring 80 is slideably mounted around the flexing fingers 74, between the barbs 78 and a retaining flange 82 proximal the first end of the endcap 70, as indicated by directional arrow 84. Sliding the collett ring 80 toward the second end 72 of the endcap 70 causes the flexing fingers 74 to flex inwardly, and sliding the collett ring toward the first end of the endcap allows the flexing fingers to return to their outwardly tapered positions. The collett ring optionally comprises a ribbed or knurled outer surface for improved manual gripping. The non-flexing fingers 76 optionally comprise flat or tapered contact faces at their free ends for contacting the subject's skin around the sampling site, and defining an opening therebetween for allowing passage of the lancet tip. The flexing fingers 74 are preferably longer than the non-flexing fingers 76, and extend beyond the non-flexing fingers in the direction of the second end 72 of the endcap 70. The second end 72 of the endcap is pressed against the skin at the sampling site, the skin is lanced, and the collett ring 80 is slid toward the second end of the endcap (prior to, during or after the lancing step) to move the flexing fingers 74 inwardly to direct subcutaneous blood toward the sampling site wound, where it is expressed for sample collection.
[00025] Figures 5a and 5b show an endcap 90 for a lancing device according to still another embodiment of the present invention. The second end 92 of this endcap embodiment comprises a contact face 94 defining a generally central opening 96 for passage of the lancet tip therethrough. At least one (four are shown) flexible finger(s) 98 are attached to the endcap proximal the first end of the endcap, and have free ends projecting beyond the contact face 94 at the second end 92 of the endcap. In the depicted embodiment, the fingers 98 are outwardly bowed, with their free ends tapered inwardly. Pressing the second end 92 of the endcap 90 against the skin around the sampling site causes HeAιngers-to-bow~ further -and-thereby-bends-the'i -free- ends-fufthef-inwareHy; compressing the skin at the sampling site to direct blood toward the wound and help prevent premature closure of the wound. In alternate embodiments, the fingers 98 are bowed inwardly with their free ends tapered outwardly, such that pressing the endcap against the skin around the sampling site bends the free ends further outwardly and tensions the skin to prevent wound closure. In still further embodiments, one or more fingers are bowed outwardly and tapered inwardly at their free ends, and one or more fingers are bowed inwardly and tapered outwardly at their free ends, such that pressure against the skin compresses the skin in one direction and tensions the skin in another direction. [00026] In a preferred method of operation according to the present invention, the second end of the endcap of the lancing device is pressed into contact with the subject's skin at the sampling site, the skin is lanced, and the sample is collected. In certain embodiments, the fingers of the endcap are actuated (as by compression, manipulation of a collett ring, or otherwise) to flex inwardly and/or outwardly, and thereby compress, tension, slide in contact with, and/or otherwise manipulate the tissue at and/or around the sampling site, prior to lancing of the skin. Alternatively or additionally, the fingers are acutated to flex inwardly and/or outwardly to manipulate the tissue at and/or around the sampling site during and/or after lancing of the skin. In this manner, subcutaneous blood can be directed by action of the fingers to pool in the area of the sampling site prior to or during lancing, and/orthe blood can be expressed out of the wound by action of the fingers during or after lancing, and/or the wound can be maintained open by the fingers to prevent premature closure.
[00027] While the invention has been described with reference to preferred and example embodiments, it will be understood by those skilled in the art that a variety of modifications, additions and deletions are within the scope of the invention, as defined by the following claims.

Claims

CLAIMSWhat is claimed is:
1. An endcap for a lancing device, the endcap comprising a first end for connection to the lancing device, a second end for contacting the skin around a sampling site, and at least one flexible finger extending toward the second end for contacting and manipulating the skin at the sampling site.
2. The endcap of Claim 1 , wherein the second end of the endcap defines an opening for passing a sharp lancet tip, and wherein the at least one flexible finger comprises a first pair of fingers extending from adjacent the opening and projecting obliquely forward and curving inward from the periphery of the opening.
3. The endcap of Claim 2, further comprising a second pair of fingers extending inward from the periphery of the opening, generally perpendicular to the first pair of fingers.
4. The endcap of Claim 2, wherein the fingers have sharp distal tips for engaging the skin at the sampling site.
5. The endcap of Claim 1 , wherein the at least one flexible finger comprises an opposed pair of compressible fingers having a hinged section that compresses when the endcap is pressed against the sampling site.
6. The endcap of Claim 5, further comprising a pair of non-compressible fingers defining a lancet opening therebetween, wherein the compressible fingers are longer than the non-compressible fingers.
7. The endcap of Claim 1 , wherein the at least one flexible finger comprises an opposed pair of outwardly flexing fingers.
8. The endcap of Claim 7, wherein the opposed pair of outwardly flexing fingers comprise contact faces that are obliquely angled and taper outwardly away from the first end of the endcap.
9. The endcap of Claim 1 , wherein the at least one flexible finger comprises at least one flexing finger tapered obliquely outwardly toward its free end, and further comprising a collett ring slideably mounted around the at least one flexing finger.
10. The endcap of Claim 9, further comprises at least one non-flexing finger having a forward contact face for contacting the skin at the sampling site.
11. The endcap of Claim 1 , wherein the at least one flexible finger comprises an opposed pair of outwardly-bowed, inwardly-flexing fingers.
12. The endcap of Claim 11 , further comprising a contact face between the pair of outwardly-bowed, inwardly-flexing fingers, and wherein free distal ends of the fingers extend beyond the contact face.
13. A lancing device for collecting a sample of body fluid from a sampling site on the skin of a subject, said lancing device comprising a lancet and a housing comprising an endcap, the lancet being movable between a first position within the housing and a second position wherein at least a sharp tip portion of the lancet extends through the endcap, wherein the endcap comprises at least one flexible contact element for contacting and manipulating the skin at the sampling site.
14. The lancing device of Claim 13, wherein the at least one flexible contact element compr-ises-two-opposed-euFved -flexible-members.
15. The lancing device of Claim 13, wherein the at least one flexible contact element comprises an opposed pair of compressible members having a hinged section that compresses when pressed against the sampling site.
16. The lancing device of Claim 13, wherein the at least one flexible contact element comprises an opposed pair of outwardly flexing members.
17. The lancing device of Claim 13, wherein the at least one flexible contact element comprises at least one flexing member tapered obliquely outwardly toward its free end, and further comprising a collett ring slideably mounted around the at least one flexing member.
18. The lancing device of Claim 13, wherein the at least one flexible contact element comprises an opposed pair of outwardly-bowed, inwardly-flexing members.
19. A lancing device having an opening for passing at least a sharp tip portion of a lancet therethrough, and a contact face surrounding said opening for contact against the skin around a sampling site, the lancing device further comprising at least one flexible member having a free end extending beyond the contact face in its unflexed state.
20. A method of lancing skin to collect a fluid sample, the method comprising: pressing a lancing device into contact with the skin adjacent a sampling site; lancing the skin at the sampling site; and actuating at least one flexible finger to flex and manipulate tissue adjacent the sampling site.
PCT/US2004/024280 2003-09-18 2004-07-28 Lancing device end cap with flexing contact elements WO2005034778A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50383903P 2003-09-18 2003-09-18
US60/503,839 2003-09-18

Publications (1)

Publication Number Publication Date
WO2005034778A1 true WO2005034778A1 (en) 2005-04-21

Family

ID=34434865

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/024280 WO2005034778A1 (en) 2003-09-18 2004-07-28 Lancing device end cap with flexing contact elements

Country Status (1)

Country Link
WO (1) WO2005034778A1 (en)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006047786A1 (en) * 2004-10-27 2006-05-04 Abbott Laboratories Blood expression device
JP2011521709A (en) * 2008-05-30 2011-07-28 インテュイティ メディカル インコーポレイテッド Body fluid collection device and collection site interface
US8690796B2 (en) 2002-04-19 2014-04-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8845550B2 (en) 2001-06-12 2014-09-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8905945B2 (en) 2002-04-19 2014-12-09 Dominique M. Freeman Method and apparatus for penetrating tissue
US8945910B2 (en) 2003-09-29 2015-02-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9034639B2 (en) 2002-12-30 2015-05-19 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US9072842B2 (en) 2002-04-19 2015-07-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9089294B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US9089678B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9144401B2 (en) 2003-06-11 2015-09-29 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US9261476B2 (en) 2004-05-20 2016-02-16 Sanofi Sa Printable hydrogel for biosensors
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9351680B2 (en) 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US9386944B2 (en) 2008-04-11 2016-07-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte detecting device
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9560993B2 (en) 2001-11-21 2017-02-07 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9561000B2 (en) 2003-12-31 2017-02-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9839386B2 (en) 2002-04-19 2017-12-12 Sanofi-Aventis Deustschland Gmbh Body fluid sampling device with capacitive sensor

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735618A (en) * 1987-07-20 1988-04-05 Henry E. Szachowicz, Jr. Protective enclosure for hypodermic syringe
US4935013A (en) * 1988-02-23 1990-06-19 Habley Medical Technology Corporation Collapsible needle cover
US5250031A (en) * 1992-12-14 1993-10-05 The George Washington University Locking needle cover
US5295972A (en) * 1992-08-04 1994-03-22 Metatech Corporation Hypodermic syringe with protective cap
US5304192A (en) * 1992-01-16 1994-04-19 Sherwood Medical Company Lancet with locking cover
US5630803A (en) * 1995-11-06 1997-05-20 Tamaro; Frank A. Safety cap assembly for needles
US20020016606A1 (en) * 2000-06-09 2002-02-07 Piet Moerman Cap for a lancing device
US6409706B1 (en) * 1999-05-14 2002-06-25 Randall A. Loy Safety syringe, fluid collection device, and associated methods

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735618A (en) * 1987-07-20 1988-04-05 Henry E. Szachowicz, Jr. Protective enclosure for hypodermic syringe
US4935013A (en) * 1988-02-23 1990-06-19 Habley Medical Technology Corporation Collapsible needle cover
US5304192A (en) * 1992-01-16 1994-04-19 Sherwood Medical Company Lancet with locking cover
US5295972A (en) * 1992-08-04 1994-03-22 Metatech Corporation Hypodermic syringe with protective cap
US5250031A (en) * 1992-12-14 1993-10-05 The George Washington University Locking needle cover
US5630803A (en) * 1995-11-06 1997-05-20 Tamaro; Frank A. Safety cap assembly for needles
US6409706B1 (en) * 1999-05-14 2002-06-25 Randall A. Loy Safety syringe, fluid collection device, and associated methods
US20020016606A1 (en) * 2000-06-09 2002-02-07 Piet Moerman Cap for a lancing device

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8845550B2 (en) 2001-06-12 2014-09-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9802007B2 (en) 2001-06-12 2017-10-31 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9694144B2 (en) 2001-06-12 2017-07-04 Sanofi-Aventis Deutschland Gmbh Sampling module device and method
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9560993B2 (en) 2001-11-21 2017-02-07 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9839386B2 (en) 2002-04-19 2017-12-12 Sanofi-Aventis Deustschland Gmbh Body fluid sampling device with capacitive sensor
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9072842B2 (en) 2002-04-19 2015-07-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9089294B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US9089678B2 (en) 2002-04-19 2015-07-28 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8905945B2 (en) 2002-04-19 2014-12-09 Dominique M. Freeman Method and apparatus for penetrating tissue
US9186468B2 (en) 2002-04-19 2015-11-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8690796B2 (en) 2002-04-19 2014-04-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9724021B2 (en) 2002-04-19 2017-08-08 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9498160B2 (en) 2002-04-19 2016-11-22 Sanofi-Aventis Deutschland Gmbh Method for penetrating tissue
US9034639B2 (en) 2002-12-30 2015-05-19 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US9144401B2 (en) 2003-06-11 2015-09-29 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US10034628B2 (en) 2003-06-11 2018-07-31 Sanofi-Aventis Deutschland Gmbh Low pain penetrating member
US8945910B2 (en) 2003-09-29 2015-02-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
US9351680B2 (en) 2003-10-14 2016-05-31 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a variable user interface
US9561000B2 (en) 2003-12-31 2017-02-07 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US9261476B2 (en) 2004-05-20 2016-02-16 Sanofi Sa Printable hydrogel for biosensors
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US7775990B2 (en) 2004-10-27 2010-08-17 Abbott Laboratories Blood expression device
US8177730B2 (en) 2004-10-27 2012-05-15 Abbott Laboratories Blood expression device
WO2006047786A1 (en) * 2004-10-27 2006-05-04 Abbott Laboratories Blood expression device
US9386944B2 (en) 2008-04-11 2016-07-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte detecting device
JP2011521709A (en) * 2008-05-30 2011-07-28 インテュイティ メディカル インコーポレイテッド Body fluid collection device and collection site interface
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation

Similar Documents

Publication Publication Date Title
WO2005034778A1 (en) Lancing device end cap with flexing contact elements
US20070032813A1 (en) Lancing device with pivoting end cap
US20090105612A1 (en) Lancing device end cap with pressure-actuated surface features
US20060287664A1 (en) Endcap for a fluid sampling device
WO2005034741A1 (en) Lancing device end cap with skin-engaging jaws
WO2005034721A2 (en) Lancing device end cap with blood-directing contact face
US20080058848A1 (en) Endcap for a Sampling Device
US5938679A (en) Apparatus and method for minimally invasive blood sampling
EP1560517B1 (en) Cap for a dermal tissue lancing device
RU2269954C2 (en) Cap for lancet device for punching dermal tissue (versions), cap for lancet device for punching tip of finger, cap for lancet device for punching curvilinear dermal tissue and lancet device for punching dermal tissue
EP1245187B1 (en) Split pressure ring for lancing device and blood drawing system
WO2005035018A2 (en) Lancing device end cap with rocking-actuated surface features
US7775990B2 (en) Blood expression device
JP4732652B2 (en) Specimen cutting device
KR100641620B1 (en) Apparatus for stimulating the efflux of a body fluid from a body part, and compression device
EP1374771B1 (en) Polygonal cross section lancet needle
US20060247670A1 (en) Lancing device with automatic lancet release
US20030220663A1 (en) Lancet device
HU219921B (en) Device for making blood test, especially from fingers
WO2003084401A1 (en) Lancet device
US20050070819A1 (en) Body fluid sampling constructions and techniques
JP2005505325A (en) Rotating penetration depth adjustment device
WO2005094683A1 (en) Split tip expression device
JP3415698B2 (en) Blood collection needle, blood collection aid and blood collection device
US20080195131A1 (en) Lancing Device End Cap With Rocking-Actuated Surface Features

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase